Canopus BioPharma Strengthens its CB1400 Platform Technology for Mucositis and Oncology Treatments Through License Agreement With Wisconsin Alumni Research Foundation

...us' Phase II oncology drug candidate, CB1400. "Securing the rights to the warf patents strengthens Canopus BioPharma's intellectual property position for ...the university to continue the cycle of investment, research and invention. warf (http://www.warf.org ) was established in 1925 as the first university-bas...

Consumer Advocates Support Patent Office on Stem Cell Patent Rejection

...inal. "Stem cell science would be best served if warf simply withdrew their overreaching claims," said J...ll claims of all three patents in March. In June warf offered counter arguments and then in October file... by Dr. James Thomson does not deserve a patent. warf holds three stem cell patents, numbers '780, '806 ...

WARF in Biological News

VistaGen, WARF sign license agreement for human embryonic stem cell technology

MADISON, VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools. VistaGen, a biotechnology company based in South San Francisco, is one of ...

WARF signs license agreement with Pfizer for human embryonic stem cells

...c stem (hES) cell patents for the development of new drug therapies. The warf license provides Pfizer the rights to work with hES cells for drug research...r of information for development of future inventions. "Our license with warf provides us with information and materials that will allow us to use their ...

'Failed' experiment yields a biocontrol agent that doesn't trigger antibiotic resistance

...onsin's booming biotechnology sector, success at ConjuGon will ultimately help nurture future scientific innovations from the university. "Because warf is the licensor of my patent, and the company is a licensee, ConjGon, if successful, will ultimately support more UW research," Filutowicz explains. ...

WARF in Biological Technology

WTN Interviews: How WARF is Reaching Out to Businesses About Technology Developed in Wisconsin

WTN Interview: Carl Gulbrandsen Editors Note: This is the first of a multi-part interview that took place earlier this fall with Carl Gulbrandsen , managing director of the Wisconsin Alumni Research Foundation (WARF) . Part one reveals Gulbrandsens perspective on the new WARF initiative c...

Mentor Licenses Botulinum From WARF and Plans Wisconsin Manufacturing Facility

MADISON, Wis. - The Wisconsin Alumni Research Foundation (WARF) has completed a licensing agreement with Mentor Corporation a California-based publicly traded company (NYSE: MNT), which gives Mentor the exclusive manufacturing and marketing rights to the proprietary botulinum toxin technology ...

New WARF investment director plans to keep steady course

Madison, Wis. The Wisconsin Alumni Research Foundation has hired a new director of investment, who has worked with the organization since December 1 and was officially announced Wednesday. WARF licenses the patents generated by University of Wisconsin-Madison researchers to companies in Mad...

UW professor and WARF receive presidential medals

Madison got a double dose of national honors on Monday as President Bush gave medals to University of Wisconsin-Madison professor Carl R. de Boor and the Wisconsin Alumni Research Foundation for achievements in mathematics and technology transfer, respectively. The 2003 National Medals of Sc...

Promega to get early access to WARF technologies under new agreement

Madison, Wis. -- Promega Corp. of suburban Madison will gain early review and easier access to new and existing life science technologies that Wisconsin Alumni Research Foundation (WARF) has available for licensing, under a new agreement signed by the two parties, Promega announced Tuesday. ...

Request to re-examine WARF stem cell patents escalates war of words

Madison, Wis. - The legal challenge to stem cell patents held by the Wisconsin Alumni Research Foundation has escalated the war of words between two states -Wisconsin and California - with both questioning the other's financial motivations. The most recent exchange came after the Public Pa...

Doyle, WARF announce partnership to lure stem cell companies

Milwaukee, Wis. - In a move designed to give Wisconsin a competitive advantage over other states, Gov. Jim Doyle has announced a partnership agreement with the Wisconsin Alumni Research Foundation guaranteeing all companies that conduct stem cell research at non-profit and academic institution...

Patent office upholds challenge to WARF stem cell patents

Madison, Wis. and Santa Monica, Calif. - The United States Patent and Trademark Office has upheld challenges to three stem cell patents held by the Wisconsin Alumni Research Foundation , but WARF is standing by the validity of the patents as the legal process continues to unfold. Every WARF...

Supreme Court ruling seen as blow to WARF stem cell patents

Madison, Wis . - Has the United States Supreme Court strengthened the case against stem cell patents held by the Wisconsin Alumni Research Foundation? The answer is yes, according to the California consumer watchdog organization that is challenging the patents, but that's not necessarily a co...

eMetagens infectious disease technology licensed by WARF

MADISON - eMetagen announced Monday it has completed a license agreement with the Wisconsin Alumni Research Foundation to commercialize technology developed by Robert Goodman and collaborators at the University of Wisconsin-Madison over the past nine years. Founded by Goodman, a UW professo...

More>>

WARF in Biological Dictionary

Secondary metabolite

...es , also known as natural products, are those products ... Secondary metabolites can be classified by their chemical structure or physical ... warf Technology Summary P02379US: A Global Regulator of Secondary Metabolite Biosynthesis in Fungi ... Secondary metabolites display a broad range ...